Stasis Labs built a cloud-connected vital signs monitoring system providing continuous, FDA-cleared remote patient monitoring for in-facility and at-home care. The platform measured six vital signs and was designed to serve the estimated 11 million under-monitored hospital beds globally. Stasis participated in the first Cedars-Sinai accelerator class in 2016.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account